These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Reactions to vaccinations against tetanus and tick-borne encephalitis caused by merthiolate (thiomersal)]. Lindemayr H; Drobil M; Ebner H Hautarzt; 1984 Apr; 35(4):192-6. PubMed ID: 6724907 [TBL] [Abstract][Full Text] [Related]
25. [Adjuvants and additives in vaccines--medical relevance]. Wiedermann-Schmidt U; Maurer W Wien Klin Wochenschr; 2005 Aug; 117(15-16):510-9. PubMed ID: 16160800 [TBL] [Abstract][Full Text] [Related]
26. Comparison of organic and inorganic mercury distribution in suckling rat. Orct T; Blanusa M; Lazarus M; Varnai VM; Kostial K J Appl Toxicol; 2006; 26(6):536-9. PubMed ID: 17080402 [TBL] [Abstract][Full Text] [Related]
27. Thimerosal: an ophthalmic preservative which acts as a hapten to elicit specific antibodies and cell mediated immunity. Cai F; Backman HA; Baines MG Curr Eye Res; 1988 Apr; 7(4):341-51. PubMed ID: 3371072 [TBL] [Abstract][Full Text] [Related]
28. A generalized reaction to thimerosal from an influenza vaccine. Lee-Wong M; Resnick D; Chong K Ann Allergy Asthma Immunol; 2005 Jan; 94(1):90-4. PubMed ID: 15702823 [TBL] [Abstract][Full Text] [Related]
29. Minimum eliciting patch test concentration of thimerosal. Lisi P; Perno P; Ottaviani M; Morelli P Contact Dermatitis; 1991 Jan; 24(1):22-6. PubMed ID: 2044366 [TBL] [Abstract][Full Text] [Related]
30. Piroxicam-induced photosensitivity and contact sensitivity to thiosalicylic acid. Serrano G; Bonillo J; Aliaga A; Cuadra J; Pujol C; Pelufo C; Cervera P; Miranda MA J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):479-83. PubMed ID: 2212148 [TBL] [Abstract][Full Text] [Related]
31. Mercurochrome allergy. Immediate and delayed hypersensitivity. Galindo PA; Feo F; García R; Gómez E; Borja J; Fernández F Allergy; 1997 Nov; 52(11):1138-41. PubMed ID: 9404570 [TBL] [Abstract][Full Text] [Related]
32. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594 [TBL] [Abstract][Full Text] [Related]
33. Systemic reactions due to thiomersal. Tosti A; Melino M; Bardazzi F Contact Dermatitis; 1986 Sep; 15(3):187-8. PubMed ID: 2946540 [No Abstract] [Full Text] [Related]
34. Thimerosal allergy and clinical relevance in Thailand. Wattanakrai P; Rajatanavin N J Med Assoc Thai; 2007 Sep; 90(9):1775-9. PubMed ID: 17957918 [TBL] [Abstract][Full Text] [Related]
39. Thimerosal exposure and disturbance of emotions specific to childhood and adolescence: A case-control study in the Vaccine Safety Datalink (VSD) database. Geier DA; Kern JK; Homme KG; Geier MR Brain Inj; 2017; 31(2):272-278. PubMed ID: 28102704 [TBL] [Abstract][Full Text] [Related]
40. Reactions to merthiolate in infants. Novák M; Kvicalová E; Friedländerová B Contact Dermatitis; 1986 Nov; 15(5):309-10. PubMed ID: 3816201 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]